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Abstract To investigate the role of disulfide bonds in the capsid
structure, a recombinant JC virus-like particle (VLP) was used.
The major capsid protein, VP1, of the JC virus was expressed in
yeast cells. The yeast-expressed VP1 was self-assembled into a
VLP. Disulfide bonds were found in the VLP which caused
dimeric and trimeric VP1 linkages as demonstrated by non-
reducing SDS^PAGE. The VLP remained intact when disulfide
bonds were reduced by dithiothreitol. The VLP without disulfide
bonds could be disassembled into capsomeres by EGTA alone,
but those with disulfide bonds could not be disassembled by
EGTA. Capsomeres were reassembled into VLPs in the presence
of calcium ions. Capsomeres formed irregular aggregations
instead of VLPs when treated with diamide to reconstitute the
disulfide bonds. These results indicate that disulfide bonds play
an important role in maintaining the integrity of the JC VLP by
protecting calcium ions from chelation. ß 2001 Published by
Elsevier Science B.V. on behalf of the Federation of European
Biochemical Societies.
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1. Introduction
Human JC virus is a small DNA virus which belongs to the
Polyomaviridae. Severe immunosuppression may result in re-
activation of the virus in human oligodendrocytes [1^3], and
cause the fatal demyelinating disease, progressive multifocal
leukoencephalopathy [4^6]. The virion of polyomavirus is
composed of three structural proteins, major capsid protein
(VP1), VP2, and VP3, as well as a viral minichromosome [7].
VP1 is the major structural protein of the capsid shell protein.
The viral capsid consists of 72 pentameric capsomeres includ-
ing 12 pentavalent and 60 hexavalent capsomeres [8]. Each
capsomere contains ¢ve VP1 molecules. The minor structural
proteins, VP2 and VP3, and the viral minichromosomes are
encapsidated in the capsid particle [9,10].
Disul¢de bonds are involved in maintaining capsid stability
of the polyomavirus. The importance of disul¢de bonds in the
polyomavirus capsid was ¢rst described by Walter and Dep-
pert [11]. Disul¢de bonds have further been demonstrated to
protect viral chromosomes from nuclease digestion in SV40
capsid [12]. More recently, disul¢de linkages were illustrated
between VP1 molecules in the capsid structure of SV40 and
polyomavirus by X-ray crystallography [8,13^15]. Besides di-
sul¢de linkages, calcium ions were also found in polyomavirus
and play an important role in viral assembly [16^18].
Although disul¢de bonds and calcium ions have been demon-
strated to be essential for maintaining the stability of the
polyomavirus capsid, the relationship between disul¢de bonds
and calcium ions is still not clear. Both a reducing agent and a
metal ion chelator are required to dissociate capsid particles
to form the pentameric capsomeres. Either a reducing agent
or a metal ion chelator alone can not disrupt the capsid par-
ticle [17,19]. Instead, capsomeres can be reassembled into a
capsid-like structure in the presence of calcium ions alone
without the involvement of disul¢de bonds [18,20,21]. There-
fore, the role of disul¢de bonds in polyomavirus assembly
needs to be further clari¢ed. In the current study, we demon-
strate that disul¢de bonds play a role in protecting calcium
ions from chelation in the JC virus-like particle (VLP).
2. Materials and methods
2.1. Expression of the JC virus VP1 protein in yeast cells
The VP1 gene of the JC virus (JCV) from a prokaryotic expressing
plasmid, pGEXJCV1 [22], was cloned into the yeast-expressing plas-
mid, pFX7, to generate pFXJCV1 (a gift of K. Sasnauskas). The
pFX7 plasmid contained GAL10 and PYK1 promoters for expressing
the VP1 protein and FDH1 gene for formaldehyde selection. The
pFXJCV1 plasmid was transfected into Saccharomyces cerevisiae
(INVSC1) yeast cells according to the methods described by Gietz
et al. [23]. INVSC1 yeast cells bearing the pFXJCV1 plasmid were
grown in YEPD medium (1% yeast extract, 2% peptone, and 2%
glucose) containing formaldehyde (¢nal concentration 30 Wl/100 ml).
The yeast cells were cultured at 30‡C with shaking for 16 h, after
which galactose (¢nal concentration 3%) was added to the culture
for induction of JC virus VP1. Cells were harvested by centrifugation
at 12 000 rpm for 20 min after 24 h of induction. The cell pellet was
resuspended in Tris bu¡er (10 mM Tris, pH 8.0, 1 mM EDTA, and
4.5 U/Wl lyticase). After a 30-min incubation, glass beads were added
to the suspension which was then vortexed for 10 min at room tem-
perature. The cell suspension was frozen and thawed (380‡C to 37‡C)
twice, followed by incubation with DNase I (1 U/Wl) and a protease
inhibitor (1 mM PMSF) for 30 min. The cell lysate was centrifuged at
14 000 rpm for 10 min, and the supernatant was collected for identi-
¢cation and puri¢cation of VP1 protein.
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2.2. Puri¢cation of the JC VLP
The supernatant of the yeast cell lysate containing VP1 protein was
subjected to 20% sucrose cushion centrifugation at 35 000 rpm for 3 h
in a SW41 Ti rotor (Beckman). The pellet was resuspended in Tris
bu¡er and diluted to a density of 1.20 g/cm3, then layered onto a ¢ve-
step CsCl velocity gradient consisting of 2 ml of 1.20, 1.25, 1.29, 1.32
and 1.35 g/cm3 CsCl solutions [20,21]. After centrifugation at 35 000
rpm for 24 h, the solution was fractionated. Every fraction was ana-
lyzed by hemagglutination assay, sodium dodecyl sulfate^polyacryl-
amide gel electrophoresis (SDS^PAGE), and Western blot. Fractions
with hemagglutination activity were collected and dialyzed against
Tris bu¡er saline (TBS) (10 mM Tris^HCl, pH 7.4, 150 mM NaCl).
The VLPs were concentrated by centrifugation at 40 000 rpm for
2.5 h.
2.3. Analysis of disul¢de bonds in the JC VLP
8 Wg of the puri¢ed VLPs was treated with SDS sample bu¡er
without the reducing agent, L-mercaptoethanol. The mixture was re-
solved in a 7% SDS^PAGE after boiling for 10 min. VP1 protein was
then transferred onto a nitrocellulose membrane after SDS^PAGE.
The membrane was then blocked with 5% non-fat milk in Tris bu¡er
(50 mM Tris^HCl, pH 7.4, 150 mM NaCl) and probed with rabbit
anti-JCV VP1 serum at a dilution ratio of 1:3000. Goat anti-rabbit
antibody, conjugated with biotin, and avidin conjugated with horse-
radish peroxidase (Vector, CA, USA) were used to detect VP1 pro-
tein.
2.4. Disassembly of the VLP
For disassembly, the puri¢ed VLPs were incubated with EGTA (10
mM) and/or dithiothreitol (DTT, 3 mM, ¢nal concentration) at room
temperature (22‡C) for 4 h [2,26]. After incubation, the mixtures were
analyzed for hemagglutination activity and examined by electron mi-
croscopy.
2.5. Reassembly of the VLP
The disassembled capsomeres were dialyzed against reassembly
bu¡er (10 mM Tris^HCl, pH 7.4, 150 mM NaCl, 10% DMSO, and
0.5 mM CaCl2) at 4‡C for 24 h [18]. The mixture was further analyzed
for hemagglutination activity and examined by electron microscopy.
2.6. Reconstitution of disul¢de bonds
8 Wg of the puri¢ed VLPs or capsomeres was incubated with 0.5
mM diamide at room temperature for 2 h. After dialysis against Tris
bu¡er, VP1 protein was resolved in a 7% SDS^PAGE without L-mer-
captoethanol and was identi¢ed by Western blot. Morphologies of
diamide-treated VLPs and capsomeres were observed by electron mi-
croscopy.
2.7. Sequential disassembly of the VLP
8 Wg of the VLPs was incubated with 3 mM DTT or 10 mM EGTA
at room temperature for 4 h. After dialysis against Tris bu¡er at 4‡C
for 24 h, the mixtures were incubated with 10 mM EGTA or 3 mM
DTT at room temperature for 4 h. Hemagglutination assay and non-
reducing SDS^PAGE were performed at each step to monitor the
integrity of the VLP and disul¢de linkages.
2.8. Hemagglutination activity and hemagglutination inhibition activity
Human type-O red blood cells (0.5%) were used to determine hem-
agglutination activities of the JC VLPs in yeast cell lysate or in each
reaction mixture. The detailed protocols for the hemagglutination
assay were described previously [24]. JC virus-positive and JC virus-
negative human sera [25] were used for the hemagglutination inhibi-
tion assay in this study.
2.9. Electron microscopy
Samples containing puri¢ed VLPs and capsomeres were mounted
on formvar-coated grids and stained with 1% uranyl acetate [19^21].
Specimens were examined with a Joel 2000-CX electron microscope
operated at 80 kV.
3. Results
3.1. Puri¢cation of the JC VLP
JC virus VP1 protein expressed in yeast cells was identi¢ed
by Western blot using JC virus VP1 mono-speci¢c antibody
(data not shown). In addition, the yeast cell lysate containing
VP1 protein showed strong hemagglutination activity (214),
and this activity was completely inhibited by JCV-positive
human serum. These results support the idea that JC virus
VP1 forms a VLP when expressed in yeast cells. Sucrose cush-
ion and CsCl density gradient centrifugations were employed
to further purify the VLPs. Fractions with strong hemaggluti-
nation activities were collected and analyzed by SDS^PAGE.
The results showed that VP1 protein was puri¢ed to near
homogeneity (data not shown). Electron microscopy also
showed that VP1 was self-assembled into a VLP which mea-
sured approximately 45 þ 3 nm, n = 50, in diameter (Fig. 1B).
3.2. Analysis of disul¢de linkages in the VLP
To demonstrate the presence of disul¢de linkages in the
VLP of JC virus, non-reducing SDS^PAGE was performed.
Monomeric VP1 protein with a molecular weight of 42 kDa
was found when the puri¢ed VLPs were resolved in a reducing
SDS^PAGE with L-mercaptoethanol (Fig. 1A, lane 1). When
Fig. 1. Disul¢de linkages in JC VLP. A: VLPs resolved by SDS^PAGE under a reducing (lane 1) or non-reducing (lane 2) condition. VLPs
treated with diamide and resolved by SDS^PAGE under a non-reducing condition (lane 3). DTT-treated VLPs (lane 4) resolved by non-reduc-
ing SDS^PAGE. VP1 protein in A was identi¢ed by Western blot. Electron microscopy of native (B) and DTT-treated (C) VLPs. Bar = 100
nm.
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the puri¢ed VLPs were resolved in SDS^PAGE without
L-mercaptoethanol, four populations of VP1 with molecular
weights of 42, 47, 80, and 120 kDa were found (Fig. 1A,
lane 2). To rule out the possibility of host protein contami-
nation of the puri¢ed VLPs, VP1 was identi¢ed by anti-JCV
VP1 serum in immunoblots (Fig. 1A). These four populations
were presumably two monomers (42 and 47 kDa), a dimer (80
kDa), and a trimer (120 kDa) of VP1 on the basis of their
molecular weights. It is not clear what causes the 47-kDa VP1
formation in a non-reducing gel. Intramolecular disul¢de link-
ages were presumably formed which caused the retarded mi-
gration, since the 47-kDa VP1 did not appear in the reducing
SDS^PAGE. Monomeric VP1 was found in VLPs (Fig. 1A,
lane 2) which might be attributable to the reduction of disul-
¢de bonds during the puri¢cation process. To rule out this
possibility, puri¢ed VLPs were treated with diamide to recon-
stitute the possible reduced disul¢de bonds during the puri¢-
cation process [26]. A similar pattern was found in non-reduc-
ing SDS^PAGE for the diamide-treated VLPs (Fig. 1A, lane
3). Therefore, these results demonstrate that the VLPs contain
monomeric, dimeric and trimeric VP1 molecules.
Previous experiments have shown that a reducing agent
alone is unable to disassemble the polyomavirus capsid struc-
ture [17,19]. To further analyze if a reducing agent is able to
break down disul¢de bonds in the capsid structure, VLPs were
treated with DTT. Disul¢de bonds in VLPs were abolished
resulting in only monomeric VP1 being present in the non-
reducing gel (Fig. 1A, lane 4). In addition, the VLP without
disul¢de bonds retained its morphological integrity (Fig. 1C).
The size of the VLPs treated with DTT (48 þ 5 nm, n = 50)
(Fig. 1C) was slightly larger than that of VLPs without DTT
treatment (45 þ 3 nm, n = 50) (Fig. 1B).
3.3. Disassembly and reassembly of the VLP
To determine the involvement of disul¢de bonds and cal-
cium ions in the JC capsid structure, puri¢ed VLPs (Fig. 2A)
were treated with DTT and EGTA. The VLPs were com-
pletely dissociated to form pentameric capsomeres (Fig. 2B).
Hemagglutination activity was also abolished when VLPs
were disrupted into capsomeres. After removing the DTT
and EGTA by dialysis, incubation of capsomeres with calcium
ions resulted in reassembly into a VLP (Fig. 2C) with hemag-
glutination activity. These results are similar to previous re-
ports [16,18,19,21] and indicate that disul¢de bonds and cal-
cium ions are involved in stabilizing the VLP, and that
calcium ions but not disul¢de bonds are required for capsid
assembly.
3.4. Reconstitution of disul¢de bonds
When treated with both DTT and EGTA, VLPs were dis-
assembled to form capsomeres (Fig. 2B). To analyze whether
disul¢de bonds are present in capsomeres, capsomeres were
resolved in non-reducing SDS^PAGE. The result showed that
capsomeres do not contain intrapentameric disul¢de bonds
(Fig. 3A, lane 1). Calcium ions alone were able to reassemble
pentameric capsomeres into VLPs as demonstrated in Fig. 2C.
The e¡ect of reconstituted disul¢de bonds on capsomeres is
not known. To understand this e¡ect, capsomeres were
treated with diamide to reconstitute the disul¢de bonds.
Non-reducing SDS^PAGE showed that both dimeric and tri-
meric forms of VP1 were re-formed (Fig. 3A, lane 2). The
results indicate that the disul¢de bonds between capsomeres
were restored. Furthermore, capsomeres with reconstituted
Fig. 2. Disassembly and reassembly of JC VLP. A: VLPs puri¢ed from yeast cells. B: Capsomeres disrupted from VLPs in the presence of
both EGTA and DTT. C: Reassembled VLPs from capsomeres incubated with calcium ions. Bar = 100 nm.
Fig. 3. Reconstitution of disul¢de bonds between capsomeres. A:
Capsomeres (lane 1) and diamide-treated capsomeres (lane 2) re-
solved by non-reducing SDS^PAGE. VP1 protein in A was identi-
¢ed by Western blot. B: Morphology of diamide-treated capso-
meres. Bar = 100 nm.
Fig. 4. Disassembly of calcium ions reassembled VLP. Reassembled
VLPs are indicated as Stock. Reassembled VLPs were treated with
EGTA or DTT alone.
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disul¢de bonds produced irregular aggregations, instead of
VLPs, with diameters of between 20 and 70 nm as observed
by electron microscopy (Fig. 3B).
3.5. Disassembly of reassembled VLP by chelator alone
Capsomeres were able to reassemble to form VLPs in the
presence of calcium ions alone (Fig. 2C). The VLPs reas-
sembled by calcium ions do not contain disul¢de bonds
(data not shown). Therefore, if disul¢de bonds play a role
in protecting calcium ions from chelation, treatment with a
chelator alone should be capable of dissociating the reas-
sembled VLPs. To verify this hypothesis, the reassembled
VLPs were treated with either EGTA or DTT. The results
showed that hemagglutination activity of the reassembled
VLPs was abolished by treatment with EGTA (Fig. 4). Hem-
agglutination activity of the reassembled VLPs was not af-
fected by treatment with DTT (Fig. 4). However, native VLPs
could only be dissociated in the presence of both EGTA and
DTT (Fig. 2B) instead of either one alone. These results are
consistent with the idea that disul¢de bonds play a role in
protecting calcium ions from chelation.
3.6. Sequential disassembly of VLP
To further demonstrate the role of disul¢de bonds in the
capsid structure, VLPs were sequentially treated with EGTA
then DTT or DTT then EGTA. After dialysis to remove the
EGTA, the EGTA-treated VLPs were incubated with DTT.
The VLPs remained intact and consequently retained their
hemagglutination activity (Fig. 5, EGTA/DTT). In contrast,
the VLPs treated with DTT ¢rst and then incubated with
EGTA were disrupted into capsomeres and, therefore, lost
their hemagglutination activity (Fig. 5, DTT/EGTA). As
shown previously, diamide is able to reconstitute disul¢de
bonds between capsomeres (Fig. 3). Therefore, if the VLPs
were to be sequentially treated with DTT and diamide, the
particles should not be sensitive to EGTA dissociation. This
hypothesis was veri¢ed by showing that the VLPs pretreated
with DTT followed by treatment with diamide and EGTA
retained their hemagglutination activity (Fig. 5, DTT/dia-
mide/EGTA), indicating that the VLP remained intact. These
results further demonstrate that disul¢de bonds protect calci-
um ions from chelation and maintain the VLP structural in-
tegrity.
4. Discussion
In this report, we showed that the JC VLP contained a
trimeric, a dimeric, and two forms of monomeric VP1 (42
and 47 kDa). These ¢ndings indicate that there are two kinds
of interpentameric disul¢de linkages present in the VLP which
cause dimeric and trimeric VP1 formation since intrapenta-
meric disul¢de bonds were not found. In addition, intra-
VP1 disul¢de bonds may also be present in the VP1 structure
which produced a slower migration band (47 kDa). However,
intra-VP1 disul¢de linkages were not detected with X-ray
crystallography of SV40 VP1 [8,14]. Therefore, formation of
the 47-kDa JC virus VP1 in a non-reducing gel needs to be
further investigated.
It is still not clear how the interpentameric disul¢de bonds
link together to form the dimer and trimer VP1 molecules.
Re¢ned X-ray crystallography of the SV40 capsid suggests
that Cys-104 at the CD loop may be involved in disul¢de
bond formation with the same cysteine of a neighboring pen-
tameric VP1 [14]. In addition, Cys-114 of polyoma VP1 (cor-
responding to Cys-104 of SV40) was found to covalently in-
teract with Cys-19 at the N-terminus of the neighboring
pentameric VP1 molecule [13]. These ¢ndings illustrate dimer-
ic, but not trimeric, VP1 linkages. Recently, Cys-9, Cys-104,
and Cys-207 of SV40 VP1 have been shown to be required for
interpentameric disul¢de linkages as demonstrated in a cell-
free system [27] and baculovirus-expressing system [28]. These
cysteines may be involved in dimeric and trimeric VP1 for-
mation in order to maintain capsid stability [27]. However, Li
et al. showed that mutation of each cysteine in the SV40 VP1
polypeptide did not a¡ect viral infectivity [29]. When replac-
ing Cys-254 with other long side chain amino acids, the in-
fectivity was reduced. This e¡ect is attributed to the longer
side chains of the replaced amino acids possibly interfering
with Ca2 ion binding during capsid assembly [29]. Cys-41,
80, 97, 200, 247, and 260 in JCV VP1 are also conserved in
SV40 VP1. The importance of each cysteine in the JC virus
capsid structure needs to be further investigated.
The VLP of JC virus can be disrupted into pentameric
capsomeres in the presence of both a reducing agent and a
chelating agent but not either one alone. In addition, the
pentameric capsomeres are able to reassemble into a VLP in
the presence of calcium ions alone without restoring the di-
sul¢de linkages. These ¢ndings are similar to those of other
reports [17,18,20,21] and indicate that calcium ions may play
a crucial role in capsid assembly. However, the role disul¢de
bonds play in the VLP of JC virus was further de¢ned in this
study. After reducing the disul¢de bonds, the DTT-pretreated
VLP could be disassembled into pentameric capsomeres by
EGTA alone. In addition, after incubating capsomeres with
calcium ions, the reassembled VLP could also be dissociated
into pentameric capsomeres by the chelator alone. These re-
sults are consistent with recent reports on murine polyomavi-
rus and suggest that disul¢de bonds might not be essential for
the formation of the VLP but important to prevent capsid
disassembly [30].
When the VLP was treated with DTT to abolish disul¢de
bonds, the structure remained intact, but it was enlarged. The
enlarged capsid structure appeared to be sensitive to EGTA
dissociation. These ¢ndings are similar to those of a previous
report which showed that the SV40 virion treated with a re-
ducing agent remained intact and was sensitive to nuclease
Fig. 5. Sequential disassembly of VLP. Puri¢ed VLPs (Stock) were
sequentially treated with EGTA then DTT (EGTA/DTT); DTT
then EGTA (DTT/EGTA); or DTT, diamide, then EGTA (DTT/di-
amide/EGTA).
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digestion of viral DNA [12]. Furthermore, although disul¢de
bonds between capsomeres were reconstituted after treatment
with diamide, irregular aggregations were formed rather than
VLPs. In contrast, capsomeres were able to reassemble into a
VLP in the presence of calcium ions alone. Recently, Ghar-
akhanian et al. also showed that disul¢de linkages were found
at a post-capsomeric stage during SV40 viral assembly [31].
Taken together, these ¢ndings imply that disul¢de linkages are
possibly not required for capsid assembly but may be essential
for maintaining capsid structural integrity.
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